Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The activities of the three drugs against other microorganisms were as follows: for staphylococci, cefamandole...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1980
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283866/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6446880/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.4.750
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!